肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1273-1276.

• 肝功能衰竭 • 上一篇    下一篇

HBV相关慢加急性肝衰竭并发急性肾损伤的危险因素及预后分析

弓瑾, 郑溦之, 陈莉, 张凯   

  1. 211100 南京 南京市江宁医院医院感染管理办公室(弓瑾),感染科(郑溦之),检验科(陈莉);
    211100 南京 江苏省人民医院胰腺研究中心(张凯)
  • 收稿日期:2026-02-26 出版日期:2026-09-30 发布日期:2026-11-16

Risk factors and prognosis of HBV-related acute-on-chronic liver failure complicated with acute kidney injury

Gong Jin1, Zheng Weizhi2, Chen Li3, Zhang Kai4   

  1. 1. Office of Hospital Infection Management, Nanjing Jiangning Hospital, Nanjing 211100,China;
    2. Department of Infectious Diseases, Nanjing Jiangning Hospital, Nanjing 211100, China;
    3. Department of Laboratory Medicine, Nanjing Jiangning Hospital, Nanjing 211100, China;
    4. Pancreatic Research Center, Jiangsu Provincial People's Hospital, Nanjing 211100, China
  • Received:2026-02-26 Online:2026-09-30 Published:2026-11-16

摘要: 目的 分析HBV所导致的慢加急性肝衰竭(HBV-ACLF)发生急性肾损伤(AKI)的影响因素及其临床结局。方法 纳入2021年1月至2025年6月期间南京市江宁医院及江苏省人民医院诊治的HBV-ACLF患者110例,比较HBV-ACLF并发与未并发AKI患者的临床资料和临床结局,通过多因素分析HBV-ACLF并发AKI的独立危险因素,并分析上述危险因素对HBV-ACLF并发AKI的区分能力。结果 HBV-ACLF并发AKI发生率为25.4%(28/110)。并发AKI组年龄为(53.1±7.2)岁,显著高于未并发AKI组的(47.8±5.4)岁(P<0.05)。并发AKI组并发其他器官衰竭、肝性脑病、自发性细菌性腹膜炎分别为6例(21.4%)、20例(71.4%)、9例(32.1%),高于未并发AKI组的4例(4.9%)、28例(34.1%)、6例(7.3%),差异有统计学意义(P<0.05)。并发AKI组TBil、BUN、sCr、CTP评分和MELD评分分别为(202.6±43.5)μmol/L、(13.2±3.3)mmol/L、(147.9±36.7)μmol/L、(11.6±1.7)分和(27.0±4.8)分,未并发AKI组分别为(134.6±34.7)μmol/L、(6.5±2.5)mmol/L、(71.2±20.3)μmol/L、(8.7±1.4)分和(20.1±3.0)分,差异具有统计学意义(P<0.05)。多因素分析结果发现HBV-ACLF并发AKI的独立危险因素是sCr、CTP评分、MELD评分(P<0.05)。随访90 d,HBV-ACLF并发AKI患者死亡16例(57.1%),而未并发AKI患者死亡18例(21.9%),差异有统计学意义(P<0.05)。sCr、CTP评分及MELD评分区分HBV-ACLF患者是否并发AKI的截断点分别为108.9 μmol/L、9.4分及23.2分。sCr诊断AKI发生的AUC高于CTP评分、MELD评分,分别为0.86、0.74、0.73(P<0.05)。sCr诊断HBV-ACLF并发AKI时的灵敏度、特异度分别为82.1%、81.7%。结论 超1/4的ACLF患者会并发AKI,sCr、CTP评分和MELD评分异常会导致HBV-ACLF患者AKI风险显著增加,需要认真预防和及时处理,提高临床救治成功率。

关键词: 慢加急性肝衰竭, 急性肾损伤, CTP评分, MELD评分

Abstract: Objective This study aimed to collect the clinical data of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF), find out the occurrence of acute kidney injury (AKI), and analyze its influencing factors and its influence on the clinical outcome. Methods 110 patients with HBV-ACLF diagnosed and treated in Nanjing Jiangning Hospital and Jiangsu Provincial People's Hospital from January 2021 to June 2025 were reviewed. Clinical data and clinical outcomes were compare between patients with and without HBV-ACLF complicated with AKI. Multivariate analysis was performed to indentify the independent risk factors of HBV-ACLF complicated with AKI, and the ability of the above risk factors to distinguish HBV-ACLF complicated with AKI was evaluated. Results The incidence of HBV-ACLF complicated with AKI was 25.4% (28/110). The age of patients with AKI was (53.1±7.2) years, which was significantly higher than that of patients without AKI [(47.8±5.4) years, P<0.05]. There were 6 cases (21.4%), 20 cases (71.4%) and 9 cases (32.1%) complicated with other organ failure, hepatic encephalopathy and spontaneous bacterial peritonitis (SBP) in the AKI group; They were significantly higher than those in the group without AKI [4 cases (4.9%), 28 cases (34.1%) and 6 cases (7.3%)], and the difference was statistically significant (P<0.05). The scores of TBil, BUN, sCr, CTP and MELD in the AKI group were (202.6±43.5) μmol/L, (13.2±3.3) mmol/L, (147.9±36.7) μmol/L, (11.6±1.7) points and (27.0±4.8) points, compared with the group without AKI [(134.6±34.7) μmol/L, (6.5±2.5) mmol/L, (71.2±20.3) μmol/L, (8.7±1.4) points and (20.1±3.0) points]. The difference was statistically significant (P<0.05). The above indicators with statistically significant differences (P<0.05) were brought into multivariate analysis, and the screened variables included age, other organ failure, hepatic encephalopathy, SBP, TBil, BUN, sCr, CTP score and MELD score. After multivariate analysis, it was found that the independent risk factors of HBV-ACLF complicated with AKI were sCr, CTP score and MELD score (P<0.05). After 90 days' follow-up, 16 patients with HBV-ACLF complicated with AKI died, with a mortality rate of 57.1%, while 18 patients without AKI died, with a mortality rate of 21.9%. The difference was statistically significant (P<0.05). The cutoff points of sCr, CTP score and MELD score to distinguish whether HBV-ACLF patients are complicated with AKI were 108.9 μmol/L, 9.4 points and 23.2 points respectively. The AUC value of AKI diagnosed by sCr was significantly higher than the CTP score and MELD score (P<0.05). The sensitivity, specificity and AUC of sCr in diagnosing HBV-ACLF complicated with AKI were 82.1%, 81.7% and 0.86, respectively. Conclusion More than 1/4 ACLF patients will be complicated with AKI. Abnormal sCr, CTP score and MELD score will significantly increase the risk of AKI in HBV-ACLF patients, which needs serious prevention and timely treatment to improve the success rate of clinical treatment.

Key words: Acute-on-chronic liver failure, Acute kidney injury, Child-Turcotte-Pugh classification, Model for End-Stage Liver Disease score